Table 1.
Summary of ZEA-induced toxicity.
Toxic Type | Animal/Cell Model | Dose | Exposure Time | Phenotypic Modulation | Pathway | Reference |
---|---|---|---|---|---|---|
Reproductive toxicity | Postweaning piglets | 3 mg/kg bw | 28 d | Vulvar malformation, decreased immune response, and disorder of the level of serum hormones. | Hypothalamic–pituitary–ovarian axis pathway. | [43] |
TM4 cells | 0~30 μM | 24 h | TM4 cell autophagy, oxidative stress, and cytoskeletal structure destruction. | PI3K/Akt/mTOR and MAPK signaling pathway. | [62] | |
TM3 cells | 50 μM | 24 h | Decreased cell viability and testosterone concentration, increased LDH, and cell apoptosis. | PI3K/Akt, PTEN/Nrf 2/Bip, and ER-stress signaling pathway. | [75] | |
Sertoli cells (SCs) | 0~80 μM | 24 h | Cell cycle arrest, inhibited SCs proliferation, and cell morphological autophagy. | PI3K/Akt/mTOR signaling pathway. | [76] | |
Hepatotoxicity | Balb/c mice | 40 mg/kg bw | 24 h | Increased MDA level, protein carbonylation, SOD activity, CAT activity, and the expression level of HSP70. | Oxidative stress pathway. | [46] |
HepG2 cells | 0~100 μM | 72 h | Decreased cell viability and the expression of liver inflammation-related factors. | Inhibit inflammatory response and liver immunity. | [47] | |
HepG2 cells | 0~40 μM | 24 h | Decreased cell viability, increased production of ROS, and regulated phase-I/II metabolism, resulting in autophagy and apoptosis. | Oxidative stress, ER-stress, and PERK/eIF2α pathway. | [49] | |
Immunotoxicity | T lymphocytes | 0~40 μM | 24 h | Decreased cell viability, damaged cell surface and intracellular ultrastructure of T lymphocytes, and decreased secretion of cytokines, resulting in cell apoptosis. | MAPK signaling pathway, TNF-α-independent JNK signaling pathway. | [53] |
HL-60, U937, PBMCs | 0~50 μM | 24 h | Decreased cell viability, increased production of ROS, and cell apoptosis. | The death receptor pathway with direct involvement of caspase-8, the mitochondrial pathway, and ER-stress pathway. | [35] | |
T lymphocytes | 0~40 μM | 48 h | Surface and intracellular ultrastructural damage of T lymphocytes. | Chemokines MIP-1α and RANTES secreted by T lymphocytes and chemokine receptor CCR2 and CCR7. | [54] | |
T lymphocytes | 0~40 μM | 24 h | Decreased cell viability and the expression of different activation signals in T cells inhibited the secretion of cytokines. | Co-stimulatory signal and PI3K/Akt/mTOR signaling pathway. | [77,78] | |
Genotoxicity | Kunming mice | 40 mg/kg bw | 28 d | Damaged kidney resulting in oxidative stress and renal cell apoptosis. | Bip, CHOP, caspase-12, and JNK signaling pathway | [59] |
TM4 cells | 0~100 μM | 24 h | Inhibited cell proliferation, cell cycle arrest, and cell apoptosis. | ROS and ER stress, ATP/AMPK pathway. | [61] | |
Carcinogenicity | INS-1 cells | 0~800 μM | 24 h | NLRP3 inflammasome activation, decreased cell viability, cell autophagy, and pyroptosis. | NF-κB p65 activation and nuclear translocation. | [79] |
Mouse granulosa cells | 10&30 μM | 72 h | Changed cell morphology, cell cycle arrest, and increased expression of genes related to tumorigenesis. | Hippo signaling pathway. | [64] | |
TM3 cells | 0~90 μM | 24 h | Decreased cell viability. | Ras, Rap1, PI3K/AKT, Foxo, and AMPK signaling pathway. | [80] | |
Gastrointestinal health | IPEC-J2 cells | 0~80 μM | 24 h | Decreased the cell viability and increased LDH activity, and inhibited cell proliferation, resulting in cell cycle arrest. | Pathways involved in the cell cycle G2 phase. | [58] |
SD mice | 0~5.0 mg/kg bw | 28 d | Impaired intestinal barrier, increased permeability and imbalance of intestinal microbiota, and increased systematic intestinal inflammation. | RhoA/ROCK signal pathway. | [65] | |
Balb/c mice | 4.5 mg/kg bw | 7 d | NLRP3 inflammasome activation and intestine inflammatory. | NLRP3 signaling pathway. | [66] | |
Endocrine-disrupting effects | Postweaning piglets | 0~3.2 mg/kg bw | 18 d | Inhibited LH secretion. | Kisspeptin–Gpr54–GnRH Pathway. | [68] |
Postweaning piglets | 0~1.5 mg/kg bw | 35 d | Inhibited follicles maturation and ovarian development. | ERs/GSK-3β-dependent Wnt-1/β-catenin signaling pathway. | [70] | |
SD mice | 0~5 mg/kg bw | 5 d | Released gonadotropin early—resulted from the advancement of vaginal opening and enlargement of the uterus at the periphery. | Hypothalamic kisspeptin–GPR54 signaling pathway. | [81] |